Autologous Dendritic Cell Therapy for Hormone-Refractory Metastatic Prostate Cancer

Clinical trial NCT01171729 · COMPLETED

Trial details

NCT number: NCT01171729
Sponsor: Samsung Medical Center
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Prostatic Cancer

Start date: 2006-07-01
Primary completion: 2010-05-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.